Показано 0 из 0
Дата |
---|
09.02.2024 |
08.02.2024 |
07.02.2024 |
06.02.2024 |
05.02.2024 |
02.02.2024 |
01.02.2024 |
31.01.2024 |
30.01.2024 |
29.01.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
28.94
|
29.00
|
28.74
|
28.74
|
28.74
|
28.74
|
|
|
|
|
28.94
|
29.01
|
27.44
|
27.44
|
27.44
|
27.44
|
|
|
|
|
27.45
|
27.50
|
27.44
|
27.44
|
27.44
|
27.44
|
|
|
|
|
27.42
|
27.49
|
27.11
|
27.11
|
27.44
|
27.44
|
|
|
13 720.00
|
2.00
|
27.29
|
27.36
|
27.11
|
27.11
|
27.11
|
27.11
|
|
|
|
|
27.21
|
27.28
|
27.19
|
27.11
|
27.19
|
27.11
|
|
|
108.44
|
2.00
|
26.99
|
27.07
|
27.19
|
27.19
|
27.19
|
27.19
|
|
|
|
|
26.99
|
27.06
|
27.19
|
27.19
|
27.19
|
27.19
|
|
|
|
|
27.11
|
27.19
|
27.19
|
27.19
|
27.19
|
27.19
|
|
|
|
|
27.13
|
27.20
|
27.19
|
27.19
|
27.19
|
27.19
|
|
|
|
|
ImmunoGen, Inc., a clinical-stage biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugate (ADC) technology.